Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration

JR Evans, JG Lawrenson - Cochrane Database of Systematic …, 2023 - cochranelibrary.com
Background Age‐related macular degeneration (AMD) is a degenerative condition of the
back of the eye that occurs in people over the age of 50 years. Antioxidants may prevent …

Glaucoma as a metabolic optic neuropathy: making the case for nicotinamide treatment in glaucoma

PA Williams, JM Harder, SWM John - Journal of glaucoma, 2017 - journals.lww.com
Mitochondrial dysfunction may be an important, if not essential, component of human
glaucoma. Using transcriptomics followed by molecular and neurobiological techniques, we …

NAD+ and Niacin Supplementation as Possible Treatments for Glaucoma and Age-Related Macular Degeneration: A Narrative Review

MR Gemae, MD Bassi, P Wang, EK Chin, DRP Almeida - Nutrients, 2024 - mdpi.com
Glaucoma and age-related macular degeneration (AMD) are progressive retinal diseases
characterized by increased oxidative stress, inflammation, and mitochondrial dysfunction …

Pharmacologic use of niacin

J Prousky, CG Millman… - Journal of Evidence …, 2011 - journals.sagepub.com
Niacin is required for a host of critical redox and adenosine diphosphate-ribosylation
reactions in metabolism. Niacin deficiency leads to the distinctive signs and symptoms of …

Lipids, lipid-lowering therapy and diabetes complications

P Valensi, S Picard - Diabetes & metabolism, 2011 - Elsevier
Cardiovascular disease (CVD) remains the primary cause of morbidity and mortality in
patients with diabetes. Lipid-lowering therapy (LLT) is often required, and statin drugs are …

[HTML][HTML] Niacinamide and neuroprotection: the glaucoma holy grail

S Bhartiya - Journal of Current Glaucoma Practice, 2022 - ncbi.nlm.nih.gov
Niacinamide and Neuroprotection: The Glaucoma Holy Grail - PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …

Reperfusion of retinal ischemia in retinal occlusive vasculitis with nicotinic acid and infliximab in Adamantiades-Behçet's disease

A Al-Moujahed, DL Hien… - American Journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Purpose To describe a case of ischemic retinal vasculitis in Adamantiades-Behçet disease
(ABD) that demonstrated significant resolution of retinal ischemia following treatment with …

Oral niacin can increase intraocular pressure

EH Tittler, DS Monteiro de Barros… - … Surgery, Lasers and …, 2008 - journals.healio.com
The intraocular pressure of a 73-year-old man with a history of primary open-angle
glaucoma had been approximately 21 and 17 mm Hg in the right and left eyes, respectively …

Retinal imaging: a new tool for studying underlying liability to cardiovascular disease in schizophrenia

MH Meier, ML Hill… - Current Psychiatry …, 2016 - ingentaconnect.com
Despite evidence that individuals with schizophrenia are disproportionately affected by
cardiovascular and cerebrovascular diseases, it is unclear if individuals with schizophrenia …

Comparison of the effect of anti-hyperlipidemic drugs from different groups on the phase profile of liposomal membrane–a fluorescence anisotropy study

S Bhandary, R Basu, S Das, P Nandy - Phase Transitions, 2010 - Taylor & Francis
The study compares the effect of incorporation of three different groups of anti-
hyperlipidemic drugs, namely niacin, simvastatin, and fenofibrate on the phase profile of …